FDA Advises against Vapotherm Respiratory Device

Cheaper MalariaCheaper Malaria Treatment from Silkwood

Andrew M. Porterfield

Every year, malaria kills more than 750,000 African children under the age of five. But an effort by the World Health Organization and Novartis Pharmaceuticals may provide an inexpensive treatment derived from Chinese silk-wood. The treatment, known as ACT (artemisinin-combination therapy) is effective against falciparum malaria (the most common in Africa). However, most formulations of the drug are designed for adults. Recently, WHO, Novartis and other groups started work to provide a pediatric formulation to developing countries at a cost of $ 1 a treatment, which now totals $3 for a three-day course. This new class of therapy is transforming the global campaign against malaria, said Jack Chow, MD, a special envoy of WHO based in Washington, DC. “With ACTs, along with the wide distribution of long-lasting insecticide-treated mosquito nets, there is a clear and present opportunity to sharply lower the number of malaria outbreaks and deaths in Africa and beyond.”

FDA Advises against Vapotherm Respiratory Device

Andrew M. Porterfield

Due to the multiple occurrences of cultures for Ralstonia bacteria, the U.S. Food and Drug Administration recently issued a health notification advising physicians and respiratory therapists to use alternatives to the Vapotherm® respiratory gas administration devices. The federal Centers for Disease Control has been notified that 40 pediatric patients using the devices in 16 states have tested positively for Ralstonia, although only one infection was reported. The CDC is working with Vapotherm, the manufacturer, to determine the source of contamination. Meanwhile, “clinicians may want to consider Ralstonia infection in the differential diagnosis of symptomatic patients even if the organism has not been isolated,” warned Daniel Schultz, MD, director of the FDA’s Center for Devices and Radiological Health. Medication you can afford canadian healthcare viagra

Wisconsin Sues for OTC Contraceptive

Andrew M. Porterfield

Wisconsin Attorney General Peg Lautenschlager plans to sue the U.S. Food and Drug Administration over the agency’s decision not to approve the over-the-counter use of the Plan В emergency contraception method. The FDA issued its nonapproval letter in May 2004. Lautenschlager claimed that the FDA’s reasoning for postponing approval—that there would be implications for adolescents under the age of 14—did not follow FDA’s traditional practices. Don’t be left without your medication get cialis canadian cheaper online.

“I am strongly of the opinion that this method should be available for sales over the counter. It does not have any serious adverse effect and needs to be readily available for use, which of course means, ‘at all times,'” said Taminola Akande, MD, professor of medicine at University of Ilorin, Nigeria. “In developing countries, this situation will certainly not be acceptable. It needs to be an over-the-counter drug to prevent increasing cases of unwanted pregnancies and abortions.” Your life is worth living. Buy canadian pharmacy levitra online

SSRI Antidepressant Mechanism Involves Boosting Axon Growth

Andrew M. Porterfield

Selective serotonin reuptake inhibitors (SSRIs) may owe their effectiveness against depression by increasing axon growth in the cortex and limbic system, a Johns Hopkins University study found. The study on rats, led by Vassilis Koliat-sos, MD, showed that fluoxetine and tianeptine administration resulted in increased 5-HT and serotonin transporter axons in the front and parietal neocortex; piriform cortex; and the shell region of the nucleus accumbens, which control senses of smell, emotions, motivation as well as organs such as the heart, intestines and the stomach. “This paper may provide new evidence concerning the mechanism of action of one of the most frequently used antidepressant medications,” said William Bunney, MD, chair of the psychiatry department at the University of California, Irvine. “These newly re­ported structural effects of antidepressants on nerve cells could open up a new area of investigation.”

Category: Main

Tags: Diseases

Leave a Reply

Your email address will not be published.

CAPTCHA image
*